Singapore, Sept. 15 -- Viome Life Sciences, Inc., the US precision health company known for its diagnostic testing and personalised nutrition recommendations, and Ezaki Glico have announced the launch of mRNA HEALTH TRACKER(R), Japan's first personalised health service built on gut bacteria mRNA analysis.

The Glico partnership marks the first international application of Viome's partnership model, which is designed to pair Viome's precision health intelligence platform with established companies that have complementary capabilities and trusted relationships with consumers.

Under this model, Viome provides the technology and infrastructure behind the personalised health experience, testing kit logistics, RNA analysis, and proprietary AI ...